- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.68 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 8 x CU: COPPER (II) ION(Non-covalent)
- 17 x CDL: CARDIOLIPIN(Non-covalent)(Covalent)
CDL.3: 18 residues within 4Å:- Chain B: F.118, P.119, R.120, L.121, L.180
- Chain C: V.25, G.28, W.32, L.149, G.153, A.157, R.164, A.177, V.180, Y.184
- Chain D: A.86, I.122, L.128
Ligand excluded by PLIPCDL.4: 28 residues within 4Å:- Chain B: M.21, G.22, P.23, K.24, G.25, N.26, L.27, I.28, L.31, I.42, M.43, F.49, L.105, F.126, W.127, L.130, I.414, W.417, F.418, M.421, W.499, R.500
- Chain G: L.86
- Chain O: F.426, F.429, R.433
- Ligands: CDL.11, CDL.28
Ligand excluded by PLIPCDL.11: 24 residues within 4Å:- Chain B: M.21, K.24, F.496, K.497, R.500
- Chain G: M.43, I.45, M.48, H.49, G.51, G.52, S.55, I.83, L.86, R.89, N.90, R.94
- Chain O: I.381, M.384, P.425, Y.428, F.429, R.433
- Ligands: CDL.4
Ligand excluded by PLIPCDL.15: 21 residues within 4Å:- Chain I: F.118, P.119, R.120, L.121, L.124, L.180
- Chain J: V.25, G.28, T.29, W.32, E.36, L.149, G.153, R.164, A.177, V.180, Y.184
- Chain K: A.86, I.122, V.125, L.128
Ligand excluded by PLIPCDL.16: 23 residues within 4Å:- Chain I: M.21, G.22, P.23, K.24, G.25, N.26, L.27, I.28, I.42, M.43, F.49, L.105, L.130, I.414, W.417, F.418, M.421, F.496, W.499, R.500
- Chain R: F.429, R.433
- Ligands: CDL.22
Ligand excluded by PLIPCDL.22: 25 residues within 4Å:- Chain I: M.21, K.24, W.493, F.496, K.497, R.500
- Chain N: I.45, M.48, G.51, S.55, I.83, R.89, N.90, W.92, R.94, R.96, W.98, I.99
- Chain R: M.384, I.422, P.425, Y.428, F.429, R.433
- Ligands: CDL.16
Ligand excluded by PLIPCDL.25: 21 residues within 4Å:- Chain D: W.91, A.119, I.122, T.123, C.126, G.127, W.134, G.135, E.137
- Chain O: R.492, K.495
- Chain Q: I.263, I.264, V.267, A.268, G.271, L.274, W.275, R.279
- Ligands: CDL.29, CDL.35
Ligand excluded by PLIPCDL.27: 16 residues within 4Å:- Chain O: I.21, Y.25, P.27, A.30, R.33, Q.34, G.229, L.232, L.234, W.236, F.237
- Chain R: Y.25, H.26, P.27, R.33
- Ligands: CDL.46
Ligand excluded by PLIPCDL.28: 22 residues within 4Å:- Chain O: H.42, W.43, V.127, R.131, F.134, R.371, P.372, R.373, A.383, I.386, I.430, T.431, W.434, C.435, L.438
- Chain Q: I.270, L.274, R.279, S.280
- Ligands: CDL.4, CDL.29, MQ9.39
Ligand excluded by PLIPCDL.29: 16 residues within 4Å:- Chain B: Y.29
- Chain D: W.90, L.94, L.97, S.98, T.101, F.120, T.123
- Chain O: R.373, W.434, L.438, L.489, K.491, R.492
- Ligands: CDL.25, CDL.28
Ligand excluded by PLIPCDL.35: 13 residues within 4Å:- Chain C: F.107, I.152, V.156, A.163, K.166, M.167
- Chain D: W.134, K.138
- Chain O: F.507, L.508
- Chain P: R.160
- Chain Q: W.275
- Ligands: CDL.25
Ligand excluded by PLIPCDL.45: 13 residues within 4Å:- Chain O: E.143, T.144, L.151, F.346, P.350, A.351, F.354, K.357, R.358
- Chain R: R.24, Y.25
- Ligands: MQ9.31, CDL.46
Ligand excluded by PLIPCDL.46: 16 residues within 4Å:- Chain O: Y.25, H.26, P.27
- Chain R: Y.25, P.27, A.30, L.31, R.33, Q.34, A.226, L.230, L.234, W.236, F.237
- Ligands: CDL.27, CDL.45
Ligand excluded by PLIPCDL.47: 14 residues within 4Å:- Chain R: H.42, W.43, R.131, F.134, R.371, P.372, R.373, I.386, T.431, W.434, C.435, L.438
- Chain T: R.279
- Ligands: CDL.48
Ligand excluded by PLIPCDL.48: 16 residues within 4Å:- Chain I: Y.29
- Chain K: W.90, S.98, T.101, F.120, T.123
- Chain R: R.373, W.434, L.438, P.488, L.489, K.491, R.492
- Chain T: R.279
- Ligands: CDL.47, CDL.56
Ligand excluded by PLIPCDL.56: 19 residues within 4Å:- Chain K: W.91, T.123, C.126, G.127, W.134, G.135, E.137
- Chain R: L.279, M.280, R.492, K.495
- Chain T: I.264, A.268, G.271, L.274, W.275, R.279
- Ligands: CDL.48, CDL.59
Ligand excluded by PLIPCDL.59: 16 residues within 4Å:- Chain J: V.104, F.107, L.111, L.155, A.163, K.166, M.167
- Chain K: F.130, W.134, K.138
- Chain R: S.506
- Chain S: L.145, I.152, R.160
- Chain T: W.275
- Ligands: CDL.56
Ligand excluded by PLIP- 4 x PLM: PALMITIC ACID(Non-covalent)
PLM.5: 2 residues within 4Å:- Chain B: Q.78
- Chain G: F.75
No protein-ligand interaction detected (PLIP)PLM.17: 1 residues within 4Å:- Chain I: M.58
No protein-ligand interaction detected (PLIP)PLM.26: 3 residues within 4Å:- Chain O: W.323, E.324, F.325
3 PLIP interactions:3 interactions with chain O- Hydrophobic interactions: O:W.323, O:W.323, O:F.325
PLM.42: 3 residues within 4Å:- Chain N: R.64
- Chain R: W.323, E.324
1 PLIP interactions:1 interactions with chain R- Hydrophobic interactions: R:W.323
- 4 x HEA: HEME-A(Non-covalent)(Covalent)
HEA.8: 24 residues within 4Å:- Chain A: V.60, I.106
- Chain B: W.151, W.260, V.267, Y.268, H.313, H.314, T.337, G.338, F.369, G.373, G.376, L.379, A.380, D.385, T.389, V.394, H.397, F.398, V.401, L.402, R.459
- Ligands: CU.7
17 PLIP interactions:2 interactions with chain A, 15 interactions with chain B,- Hydrophobic interactions: A:V.60, A:I.106, B:W.151, B:V.267, B:T.337, B:F.369, B:L.379, B:V.394, B:F.398, B:F.398, B:V.401, B:L.402
- Hydrogen bonds: B:Y.268
- Salt bridges: B:R.459
- pi-Cation interactions: B:H.264, B:H.313
- Metal complexes: B:H.397
HEA.9: 27 residues within 4Å:- Chain B: F.52, L.53, G.56, L.57, A.59, L.60, M.62, R.63, F.79, F.83, H.86, M.90, L.91, W.151, Y.392, I.395, F.398, H.399, F.403, I.406, F.446, Q.449, R.459, R.460, A.481, L.484, G.485
27 PLIP interactions:27 interactions with chain B,- Hydrophobic interactions: B:F.52, B:L.53, B:L.53, B:L.57, B:L.57, B:A.59, B:L.60, B:F.83, B:M.90, B:L.91, B:I.395, B:F.398, B:F.398, B:I.406, B:F.446, B:A.481
- Hydrogen bonds: B:W.151, B:Y.392, B:Q.449, B:R.460
- Salt bridges: B:R.459, B:R.460
- pi-Stacking: B:H.399, B:H.399, B:F.446
- Metal complexes: B:H.86, B:H.399
HEA.19: 28 residues within 4Å:- Chain H: I.105, I.106
- Chain I: W.151, W.260, V.267, Y.268, H.313, H.314, T.330, A.334, T.337, G.338, F.369, G.373, G.376, V.377, L.379, A.380, D.385, T.389, V.394, H.397, F.398, V.401, L.402, T.405, R.459
- Ligands: CU.18
22 PLIP interactions:20 interactions with chain I, 2 interactions with chain H,- Hydrophobic interactions: I:W.151, I:V.267, I:T.330, I:T.337, I:F.369, I:V.377, I:L.379, I:V.394, I:F.398, I:V.401, I:L.402, I:T.405, H:I.105, H:I.106
- Hydrogen bonds: I:Y.268, I:Y.268, I:T.389
- Salt bridges: I:R.459
- pi-Stacking: I:H.313
- pi-Cation interactions: I:H.264, I:H.264
- Metal complexes: I:H.397
HEA.20: 27 residues within 4Å:- Chain I: F.52, L.53, G.56, L.57, A.59, L.60, M.62, R.63, F.79, F.83, H.86, G.87, M.90, L.91, W.151, Y.392, I.395, F.398, H.399, F.403, F.446, Q.449, R.459, R.460, A.481, L.484, G.485
22 PLIP interactions:22 interactions with chain I,- Hydrophobic interactions: I:F.52, I:L.53, I:L.57, I:A.59, I:L.60, I:M.90, I:L.91, I:I.395, I:F.398, I:A.481
- Hydrogen bonds: I:W.151, I:Q.449, I:R.460
- Salt bridges: I:R.459, I:R.460
- pi-Stacking: I:H.86, I:F.398, I:H.399, I:H.399, I:F.446
- Metal complexes: I:H.86, I:H.399
- 2 x 9Y0: (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate(Non-covalent)
9Y0.10: 10 residues within 4Å:- Chain B: M.173
- Chain C: V.125, T.130, I.131, P.132, Y.141, L.142, G.145
- Chain D: A.102, A.106
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:I.131, C:Y.141, C:L.142, D:A.106
9Y0.21: 10 residues within 4Å:- Chain I: M.173
- Chain J: V.125, T.130, I.131, P.132, Y.141, G.145
- Chain K: F.99, A.102, A.106
3 PLIP interactions:1 interactions with chain J, 2 interactions with chain K- Hydrophobic interactions: J:Y.141, K:F.99, K:A.106
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.23: 21 residues within 4Å:- Chain O: F.45, G.48, E.49, F.121, I.125, H.128, L.129, R.131, I.132, A.137, R.142, N.145, W.146, G.149, L.152, H.231, L.232, V.235, H.240, T.241
- Ligands: MQ9.30
21 PLIP interactions:21 interactions with chain O,- Hydrophobic interactions: O:F.121, O:I.125, O:I.125, O:L.129, O:I.132, O:I.132, O:A.137, O:W.146, O:L.152, O:L.232, O:V.235, O:V.235
- Hydrogen bonds: O:G.48, O:T.241
- Salt bridges: O:H.128, O:R.131, O:R.142, O:H.240, O:H.240
- Metal complexes: O:H.128, O:H.231
HEM.24: 22 residues within 4Å:- Chain O: F.55, L.58, L.59, G.62, V.63, L.65, T.66, R.111, H.114, H.115, A.118, E.159, G.160, G.163, Y.164, L.166, P.167, Y.213, H.216, P.221, N.287
- Chain R: L.218
16 PLIP interactions:1 interactions with chain R, 15 interactions with chain O,- Hydrophobic interactions: R:L.218, O:F.55, O:L.58, O:L.59, O:V.63, O:L.65, O:E.159, O:L.166, O:Y.213, O:P.221
- Hydrogen bonds: O:N.287
- Salt bridges: O:R.111, O:R.111, O:H.115
- Metal complexes: O:H.114, O:H.216
HEM.43: 20 residues within 4Å:- Chain R: F.45, G.48, E.49, F.121, I.125, H.128, L.129, R.131, I.132, A.137, N.145, W.146, G.149, L.152, H.231, L.232, V.235, H.240, T.241
- Ligands: MQ9.31
23 PLIP interactions:23 interactions with chain R,- Hydrophobic interactions: R:F.121, R:I.125, R:I.125, R:L.129, R:I.132, R:I.132, R:A.137, R:N.145, R:W.146, R:L.152, R:L.232, R:V.235, R:V.235
- Hydrogen bonds: R:G.48, R:T.241
- Salt bridges: R:H.128, R:R.131, R:R.131, R:R.142, R:H.240, R:H.240
- Metal complexes: R:H.128, R:H.231
HEM.44: 20 residues within 4Å:- Chain O: L.218
- Chain R: F.55, L.58, L.59, G.62, V.63, L.65, T.66, R.111, H.114, H.115, A.118, E.159, G.160, G.163, Y.164, L.166, P.167, H.216, N.287
16 PLIP interactions:15 interactions with chain R, 1 interactions with chain O,- Hydrophobic interactions: R:F.55, R:L.58, R:L.59, R:L.65, R:L.65, R:T.66, R:E.159, R:Y.164, R:L.166, O:L.218
- Hydrogen bonds: R:N.287
- Salt bridges: R:R.111, R:R.111, R:H.115
- Metal complexes: R:H.114, R:H.216
- 10 x MQ9: MENAQUINONE-9(Non-covalent)(Covalent)
MQ9.30: 13 residues within 4Å:- Chain O: F.39, F.45, E.49, L.52, L.232, V.235, W.236, H.240, F.262
- Chain R: I.223
- Chain S: F.222
- Ligands: HEM.23, MQ9.33
7 PLIP interactions:5 interactions with chain O, 1 interactions with chain R, 1 interactions with chain S- Hydrophobic interactions: O:L.52, O:L.232, O:W.236, O:F.262, R:I.223, S:F.222
- pi-Stacking: O:F.39
MQ9.31: 16 residues within 4Å:- Chain O: L.155, F.158, L.215, L.219, L.220, I.223
- Chain R: F.39, E.49, L.52, L.59, V.63, L.232, W.236, F.262
- Ligands: HEM.43, CDL.45
13 PLIP interactions:8 interactions with chain R, 5 interactions with chain O- Hydrophobic interactions: R:F.39, R:E.49, R:L.52, R:L.59, R:V.63, R:V.63, R:F.262, O:L.155, O:F.158, O:L.219, O:L.220, O:I.223
- Hydrogen bonds: R:E.49
MQ9.32: 14 residues within 4Å:- Chain O: F.158, A.179, L.180, I.183, T.184, M.187, A.339, V.340, M.342, G.343, L.344, V.347, L.355, R.358
5 PLIP interactions:5 interactions with chain O- Hydrophobic interactions: O:F.158, O:A.179, O:L.180, O:V.347, O:L.355
MQ9.33: 14 residues within 4Å:- Chain O: F.109, A.263, F.264, G.267, F.270, A.271
- Chain P: F.143, I.150, A.154
- Chain S: F.207, T.218, A.221, F.222
- Ligands: MQ9.30
12 PLIP interactions:2 interactions with chain P, 4 interactions with chain S, 6 interactions with chain O- Hydrophobic interactions: P:I.150, P:A.154, S:F.207, S:T.218, S:A.221, S:F.222, O:F.109, O:A.263, O:F.264, O:F.270, O:F.270, O:A.271
MQ9.38: 16 residues within 4Å:- Chain B: L.134, I.135
- Chain D: L.97, S.100, V.104, W.112
- Chain O: M.397, I.400, K.404, F.405, I.407
- Chain Q: Y.247, L.249, G.250, P.256, M.259
13 PLIP interactions:6 interactions with chain D, 4 interactions with chain O, 2 interactions with chain B, 1 interactions with chain Q- Hydrophobic interactions: D:L.97, D:V.104, D:W.112, D:W.112, O:I.400, O:F.405, O:F.405, O:I.407, B:L.134, B:I.135, Q:P.256
- pi-Stacking: D:W.112, D:W.112
MQ9.39: 20 residues within 4Å:- Chain O: M.126, V.127, L.129, F.133, F.134, F.308, W.312, V.345, L.349, Y.352, A.385, F.388, Y.389, M.390, T.393, M.397
- Chain Q: M.259, W.262, I.263
- Ligands: CDL.28
19 PLIP interactions:15 interactions with chain O, 4 interactions with chain Q- Hydrophobic interactions: O:M.126, O:V.127, O:L.129, O:F.133, O:F.133, O:F.134, O:F.308, O:W.312, O:V.345, O:L.349, O:Y.352, O:F.388, O:Y.389, O:Y.389, O:T.393, Q:W.262, Q:W.262, Q:I.263
- pi-Stacking: Q:W.262
MQ9.49: 17 residues within 4Å:- Chain P: M.211, F.214, A.221, F.222
- Chain R: I.60, F.109, V.110, A.263, F.264, S.266, G.267, F.270, A.271
- Chain S: F.143, I.147, I.150, A.154
13 PLIP interactions:4 interactions with chain S, 7 interactions with chain R, 2 interactions with chain P- Hydrophobic interactions: S:F.143, S:I.147, S:I.150, S:A.154, R:I.60, R:F.109, R:V.110, R:A.263, R:F.264, R:F.270, R:A.271, P:F.214, P:A.221
MQ9.50: 9 residues within 4Å:- Chain R: A.179, L.180, I.183, M.187, A.339, V.340, M.342, G.343, V.347
3 PLIP interactions:3 interactions with chain R- Hydrophobic interactions: R:A.179, R:L.180, R:V.347
MQ9.57: 17 residues within 4Å:- Chain I: L.134, I.135
- Chain K: T.101, W.112
- Chain R: L.394, M.397, I.401, K.404, F.405, I.407, T.412, I.415
- Chain T: Y.247, L.249, G.250, P.256, M.259
13 PLIP interactions:5 interactions with chain R, 2 interactions with chain T, 4 interactions with chain K, 2 interactions with chain I- Hydrophobic interactions: R:L.394, R:I.401, R:F.405, R:I.407, R:I.415, T:P.256, T:M.259, K:W.112, K:W.112, I:L.134, I:I.135
- pi-Stacking: K:W.112, K:W.112
MQ9.58: 14 residues within 4Å:- Chain R: M.126, F.133, M.157, F.308, V.345, L.349, A.385, I.386, Y.389, M.390, T.393
- Chain T: M.259, W.262, I.270
18 PLIP interactions:14 interactions with chain R, 4 interactions with chain T- Hydrophobic interactions: R:F.133, R:F.133, R:F.133, R:F.308, R:V.345, R:V.345, R:L.349, R:A.385, R:I.386, R:Y.389, R:Y.389, R:Y.389, R:T.393, T:W.262, T:W.262, T:I.270
- Hydrogen bonds: R:Y.389
- pi-Stacking: T:W.262
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
FES.34: 9 residues within 4Å:- Chain P: C.353, H.355, L.356, C.358, C.372, C.374, H.375, Q.376, S.377
4 PLIP interactions:4 interactions with chain P,- Metal complexes: P:C.353, P:H.355, P:C.372, P:H.375
FES.51: 8 residues within 4Å:- Chain S: C.353, H.355, L.356, C.358, C.372, C.374, H.375, S.377
4 PLIP interactions:4 interactions with chain S,- Metal complexes: S:C.353, S:H.355, S:C.372, S:H.375
- 4 x 9YF: (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate(Non-covalent)
9YF.36: 3 residues within 4Å:- Chain P: W.231, W.246
- Ligands: 9YF.37
No protein-ligand interaction detected (PLIP)9YF.37: 10 residues within 4Å:- Chain O: W.193
- Chain P: G.224, G.225, I.227, K.228, N.229, K.232
- Chain R: R.105
- Chain S: W.119
- Ligands: 9YF.36
11 PLIP interactions:2 interactions with chain R, 1 interactions with chain S, 7 interactions with chain P, 1 interactions with chain O- Hydrogen bonds: R:R.105, S:W.119, P:G.224, P:G.225, P:I.227, P:K.228, P:N.229
- Salt bridges: R:R.105, P:K.232
- Hydrophobic interactions: P:I.227, O:W.193
9YF.52: 11 residues within 4Å:- Chain O: E.103, R.105
- Chain P: W.119
- Chain R: W.193, L.194
- Chain S: G.224, G.225, I.227, K.228, N.229, K.232
13 PLIP interactions:5 interactions with chain S, 1 interactions with chain P, 4 interactions with chain O, 3 interactions with chain R- Hydrophobic interactions: S:I.227, R:W.193, R:W.193, R:L.194
- Hydrogen bonds: S:G.225, S:K.228, S:N.229, P:W.119, O:E.103, O:R.105, O:R.105
- Salt bridges: S:K.232, O:R.105
9YF.53: 5 residues within 4Å:- Chain R: W.193
- Chain S: W.231, W.246, W.424, E.425
1 PLIP interactions:1 interactions with chain S- Hydrogen bonds: S:W.246
- 4 x HEC: HEME C(Non-covalent)(Covalent)
HEC.40: 13 residues within 4Å:- Chain Q: S.72, C.73, C.76, H.77, H.87, P.89, L.91, V.94, V.103, M.108, P.109, A.110, M.111
7 PLIP interactions:7 interactions with chain Q,- Hydrophobic interactions: Q:C.73, Q:C.76, Q:P.89, Q:L.91, Q:L.91, Q:V.103
- Metal complexes: Q:H.77
HEC.41: 19 residues within 4Å:- Chain P: Y.363
- Chain Q: F.101, R.107, N.173, C.174, C.177, H.178, L.187, Y.192, P.194, L.196, I.204, A.207, P.212, Q.213, N.214, M.215, P.216, F.218
14 PLIP interactions:14 interactions with chain Q,- Hydrophobic interactions: Q:F.101, Q:L.187, Q:L.187, Q:P.194, Q:L.196, Q:I.204, Q:A.207, Q:P.212, Q:M.215, Q:F.218
- Hydrogen bonds: Q:Q.213
- Salt bridges: Q:R.107, Q:R.107
- Metal complexes: Q:H.178
HEC.54: 15 residues within 4Å:- Chain S: Q.366
- Chain T: S.72, C.73, C.76, H.77, H.87, P.89, L.91, V.94, A.98, M.108, P.109, A.110, M.111, Q.213
8 PLIP interactions:7 interactions with chain T, 1 interactions with chain S,- Hydrophobic interactions: T:C.76, T:H.87, T:P.89, T:L.91, T:A.98, T:P.109
- Metal complexes: T:H.77
- Hydrogen bonds: S:Q.366
HEC.55: 20 residues within 4Å:- Chain T: R.107, A.117, R.119, N.173, C.174, C.177, H.178, L.187, Y.192, P.194, L.196, A.199, I.204, M.208, P.212, Q.213, N.214, M.215, P.216, F.218
13 PLIP interactions:13 interactions with chain T,- Hydrophobic interactions: T:L.187, T:L.187, T:P.194, T:L.196, T:I.204, T:P.212, T:M.215, T:F.218
- Hydrogen bonds: T:Q.213
- Salt bridges: T:R.107, T:R.107, T:R.119
- Metal complexes: T:H.178
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, S. et al., Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates. Elife (2021)
- Release Date
- 2021-10-13
- Peptides
- Cytochrome c oxidase subunit 2: AH
Cytochrome c oxidase subunit 1: BI
Cytochrome c oxidase subunit 3: CJ
Cytochrome c oxidase polypeptide 4: DK
Cytochrome c oxidase subunit CtaJ: EL
Uncharacterized protein MSMEG_4692/MSMEI_4575: FM
Prokaryotic respiratory supercomplex associate factor 1 PRSAF1: GN
Cytochrome bc1 complex cytochrome b subunit: OR
Cytochrome bc1 complex Rieske iron-sulfur subunit: PS
Cytochrome bc1 complex cytochrome c subunit: QT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EH
QB
FI
RC
GJ
SD
HK
TE
IL
UF
JM
VG
DN
PO
NR
BP
MS
AQ
OT
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.68 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 8 x CU: COPPER (II) ION(Non-covalent)
- 17 x CDL: CARDIOLIPIN(Non-covalent)(Covalent)
- 4 x PLM: PALMITIC ACID(Non-covalent)
- 4 x HEA: HEME-A(Non-covalent)(Covalent)
- 2 x 9Y0: (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 10 x MQ9: MENAQUINONE-9(Non-covalent)(Covalent)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 4 x 9YF: (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate(Non-covalent)
- 4 x HEC: HEME C(Non-covalent)(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, S. et al., Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates. Elife (2021)
- Release Date
- 2021-10-13
- Peptides
- Cytochrome c oxidase subunit 2: AH
Cytochrome c oxidase subunit 1: BI
Cytochrome c oxidase subunit 3: CJ
Cytochrome c oxidase polypeptide 4: DK
Cytochrome c oxidase subunit CtaJ: EL
Uncharacterized protein MSMEG_4692/MSMEI_4575: FM
Prokaryotic respiratory supercomplex associate factor 1 PRSAF1: GN
Cytochrome bc1 complex cytochrome b subunit: OR
Cytochrome bc1 complex Rieske iron-sulfur subunit: PS
Cytochrome bc1 complex cytochrome c subunit: QT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EH
QB
FI
RC
GJ
SD
HK
TE
IL
UF
JM
VG
DN
PO
NR
BP
MS
AQ
OT
C - Membrane
-
We predict this structure to be a membrane protein.